Ledger.Open graph →
SEC Form D · Amendment · filed February 2, 2017

KP BIOSCIENCES, INC

Offering
$1.2M
Sold
$280K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
OREM, UT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Matthew Cryer · Orem, UTExec · DirectorSteve Smith · Orem, UTDirectorRobert Allen · Orem, UTDirectorKyle Lane · Orem, UTExec · DirectorKeith E. Stewart · Minneapolis, MNDirectorHarlan E. Langstraat · Minneapolis, MNExec · DirectorJeremy E. Friese · Minneapolis, MNDirectorTroy D. Kopischke · Minneapolis, MNExec · DirectorJason Rea · Luxembourg, LuxembourgDirectorPeter Dickinson · Kirchberg, LuxembourgExec · DirectorCleve S. Adams · Kansas City, MODirectorSage S. Osterfeld · Kansas City, MOExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗